AbbVieABBV
AbbVie on podcasts: where it advertises, what it's offering listeners, and what hosts say about it when they're not being paid.
Sponsorships
No ad reads on tracked podcasts in the last 30 days. Hosts are talking about it anyway — see the earned side.
What hosts are saying
Most mentioned on
In their words
“'one good example would be um let's say ABV and Humira. They patented every single little thing around that drug that they could. It was a huge winner for them and they wanted to keep it um protected as long as they possibly could... They'll patent the drug. They'll patent the formulation. They'll patent the salts. They'll patent the auto injector... and the method of manufacturing.'”
Discussed in context of aggressive patent strategies to extend monopoly protection and price manipulation of drugs like Humira.
▶ Hear it“Combination medicine with Abbvie, the US firm for lymphoma. They've had positive results from a trial there. Analysts are saying it's well worth the wait as it's a significant win.”
Positive trial results in combination medicine with Genmab for lymphoma, part of successful tie-ups.
▶ Hear it“it was called pharmace um people didn't believe it at first then they brought to the drug in the end in the end that company pharmaceylic was sold to um Abby V for something in the region of um 20 odd billion dollars”
AbbVie is mentioned as the acquirer of Pharmacyclics in a historical transaction without evaluative commentary.
▶ Hear itThe full picture
A weekly email with where each one advertised and what hosts said about them. Free.